Comparison of the Efficacy and Safety of Risperidone Versus Risperidone Plus Low Dose of Haloperidol in the Treatment of Schizophrenia

• Status: Terminated
• Trial end date: 2009-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare the efficacy and safety of risperidone and risperidone plus low dose of haloperidol in the acutely schizophrenic patients.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Kaohsiung Kai-Suan Psychiatric Hospital
• Treatments: Haloperidol; Haloperidol decanoate; Risperidone

Criteria

Inclusion Criteria:

• Diagnosis of schizophrenia

• Clinical Global Impression large than 3

• Written informed consent

Exclusion Criteria:

• Comorbid of substance abuse/dependence

• Present or history of tardive dyskinesis or neuroleptic malignant syndromes

• Severe physical problems

• pregnant or lactating women